Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. According to Zacks, “Kitov Pharmaceuticals Holdings Ltd. is a pharmaceutical company which focused on the development of therapeutic candidates. The company’s product candidate consists of […]
